Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...

BPH prostate treatment market is evolving toward a more patient-focused, technology-driven ecosystem. As innovation in both pharmaceuticals and minimally invasive procedures accelerates, companies ...

These new findings are important as α-blockers (ABs) are the most prescribed class of medications for patients with benign prostatic hyperplasia (BPH), but the cardiovascular safety profile of this ...

The US Food and Drug Administration has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia (BPH). Designed and marketed ...

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...

Prostate artery embolization (PAE) provides long-term effectiveness in treating urinary symptoms from an enlarged prostate gland, according to new research to be presented at the Society of ...

Benign Prostatic Hyperplasia: Causes, Symptoms, Diagnosis, and Treatments: By Anjali Srivastava Benign Prostatic Hyperplasia (BPH) is a common condition that affects many men as they age, involving ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Add Yahoo as a preferred source to see more of our stories on Google. Buckingham Palace officials revealed that King Charles III has been diagnosed with cancer. Last month, the king, 75, underwent ...